EVOK Logo.jpg
Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
September 04, 2024 09:20 ET | Evoke Pharma, Inc.
SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 3rd Annual Kidney Conference to be Held Virtually on July 15, 2024
July 09, 2024 07:57 ET | ZyVersa Therapeutics
ZyVersa welcomes one-on-one meetings at the HCW Kidney Conference on July 15, 2024.
ihl_logo.png
Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference
September 08, 2022 09:15 ET | Incannex Healthcare
MELBOURNE, Australia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal...
01_PrimaryLogo_Color_BlueX-100.jpg
Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 07, 2022 16:05 ET | Praxis Precision Medicines, Inc.
BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
Atyr_Logo.png
aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
September 06, 2022 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO , Sept. 06, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Official_Bellicum_Logo_RGB.jpg
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
September 01, 2022 07:30 ET | Bellicum Pharmaceuticals, Inc.
HOUSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick...
Atyr_Logo.png
aTyr Pharma to Present at Upcoming Investor Conferences in May
May 10, 2022 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary tRNA...
Atyr_Logo.png
aTyr Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
January 04, 2022 08:03 ET | aTyr Pharma, Inc.
SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Obseva Logo highresolution.jpg
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
January 03, 2022 07:00 ET | ObsEva SA
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
Obseva Logo highresolution.jpg
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
January 03, 2022 01:00 ET | ObsEva SA
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...